Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Monopar Therapeutics Inc. (MNPR) had Return on Equity of -4.90% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.62M |
|
-- |
|
-- |
|
$3.22M |
|
$-3.22M |
|
$0.60M |
|
$-2.62M |
|
$-2.62M |
|
$-2.62M |
|
$-2.62M |
|
$-2.62M |
|
$-2.62M |
|
$-3.22M |
|
$-3.22M |
|
6.99M |
|
6.99M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$55.08M |
|
-- |
|
$0.01M |
|
$55.09M |
|
$1.49M |
|
-- |
|
-- |
|
$1.49M |
|
$53.59M |
|
$53.59M |
|
$53.59M |
|
6.12M |
|
| Cash Flow Statement Financials | |
$-5.66M |
|
$-0.33M |
|
$-0.12M |
|
$45.82M |
|
$39.71M |
|
$-6.10M |
|
$1.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
36.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-4.90% |
-4.90% |
|
-4.77% |
|
-4.90% |
|
$8.76 |
|
$-0.81 |
|
$-0.81 |
|